bf/NYSE:EVH_icon.jpeg

NYSE:EVH

Evolent Health, Inc.

  • Stock

USD

Last Close

23.31

17/05 20:00

Market Cap

3.48B

Beta: 1.54

Volume Today

2.19M

Avg: 941.80K

PE Ratio

−36.42

PFCF: 61.17

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-10.19M
-
-30.51M
199.38%
-21.95M
28.06%
37.63M
271.43%
-35.79M
195.11%
-297.59M
731.58%
-376.66M
26.57%
-362.07M
3.87%
-207.96M
42.56%
average payables
988K
-
8.35M
745.09%
30.30M
262.84%
43.41M
43.29%
94.84M
118.48%
92.12M
2.87%
34.78M
62.25%
64.08M
84.24%
76.63M
19.59%
52.71M
31.21%
average receivables
5.26M
-
10.19M
93.74%
30.51M
199.38%
54.79M
79.60%
75.63M
38.03%
79.86M
5.60%
101.87M
27.55%
128.46M
26.11%
192.64M
49.96%
350.72M
82.05%
book value per share
0.81
-
-0.05
106.67%
25.84
47,819.36%
15.60
39.63%
15.71
0.69%
14.79
5.85%
11.20
24.28%
7.30
34.85%
8.06
10.47%
9.17
13.81%
11.20
22.12%
capex per share
-0.27
-
-0.29
5.71%
-0.26
10.18%
-0.34
32.99%
-0.43
25.51%
-0.51
18.17%
-0.43
15.64%
-0.35
19.56%
-0.29
16.36%
-0.41
41.04%
-3.75
815.52%
capex to depreciation
-8.64
-
-0.91
-
-0.90
0.85%
-0.86
4.56%
-0.89
3.27%
-0.58
34.34%
-0.48
17.82%
-0.42
13.20%
-0.57
37.19%
-4.31
655.23%
capex to operating cash flow
0.77
-
0.15
80.81%
0.33
123.61%
0.44
33.07%
1.00
127.81%
1.92
92.27%
0.83
56.49%
1.82
118.00%
-0.64
135.49%
3.32
614.98%
-2.92
188.08%
capex to revenue
-0.41
-
-0.07
-
-0.06
9.17%
-0.06
4.82%
-0.06
1.49%
-0.04
33.44%
-0.03
31.34%
-0.03
4.55%
-0.03
3.12%
-0.21
648.34%
cash per share
1.78
-
6.17
-
3.97
35.66%
4.67
17.67%
2.96
36.62%
1.25
57.87%
4.05
224.81%
3.97
2.01%
2.16
45.56%
1.86
14.16%
days of inventory on hand
-129.60
-
-95.58
26.25%
-4.42
95.38%
87.42
2,077.59%
-106.77
222.14%
-231.63
116.94%
-171.09
26.14%
-146.62
14.30%
0.00
100.00%
days payables outstanding
24.03
-
106.19
-
103.24
2.78%
58.17
43.65%
163.40
180.88%
26.67
83.68%
16.69
37.43%
53.34
219.59%
20.15
62.21%
11.71
41.88%
days sales outstanding
149.58
-
76.79
-
58.35
24.01%
57.86
0.84%
47.91
17.19%
33.39
30.32%
45.09
35.07%
52.50
16.43%
68.76
30.96%
83.03
20.76%
debt to assets
0.10
-
0.10
-
0.09
7.75%
0.06
38.19%
0.25
330.70%
0.26
6.66%
0.20
24.75%
0.26
32.60%
0.23
13.59%
debt to equity
0.33
-
0.17
-
0.12
29.86%
0.09
28.33%
0.40
364.57%
0.58
45.23%
0.40
30.37%
0.55
37.01%
0.49
12.11%
dividend yield
0.01
-
0.00
96.28%
0.01
936.31%
0.01
9.59%
earnings yield
0.03
-
-0.04
226.09%
1.09
3,220.19%
-0.24
121.94%
-0.08
68.02%
-0.03
55.47%
-0.41
1,101.19%
-0.25
40.11%
-0.01
94.82%
-0.01
44.11%
-0.04
444.68%
enterprise value
653.07M
-
720.96M
10.40%
158.59M
78.00%
652.18M
311.25%
674.48M
3.42%
1.54B
127.67%
1.01B
34.02%
1.38B
36.27%
2.40B
73.51%
2.92B
21.84%
4.13B
41.37%
enterprise value over ebitda
-9.87
-
-28.56
189.45%
-0.35
98.77%
6.74
2,010.87%
-16.86
350.36%
-186.00
1,003.07%
-15.48
91.68%
58.52
478.13%
26.53
54.66%
396.60
1,394.67%
0.12
99.97%
ev to operating cash flow
-47.92
-
-9.60
79.96%
-8.00
16.70%
-18.37
129.64%
-24.12
31.35%
-74.36
208.23%
-23.76
68.05%
-85.10
258.17%
61.83
172.66%
-252.66
508.65%
28.94
111.45%
ev to sales
25.44
-
1.64
-
2.57
56.74%
1.55
39.56%
2.45
57.92%
1.20
51.12%
1.35
12.81%
2.64
95.39%
2.16
18.17%
2.10
2.68%
free cash flow per share
-0.63
-
-2.25
257.87%
-1.05
53.47%
-1.13
8.11%
-0.87
23.48%
-0.78
10.24%
-0.95
21.94%
-0.54
43.31%
0.16
129.72%
-0.53
433.10%
-2.47
363.03%
free cash flow yield
-0.03
-
-0.12
257.87%
-0.09
27.54%
-0.08
11.54%
-0.07
7.93%
-0.04
44.66%
-0.10
168.80%
-0.03
68.00%
0.01
117.22%
-0.02
428.24%
-0.07
293.64%
graham net net
0.13
-
-1.06
931.90%
3.16
399.11%
-2.19
169.40%
1.31
159.95%
-2.62
299.65%
-5.87
123.70%
-6.29
7.20%
-5.11
18.70%
-8.24
61.18%
-8.02
2.64%
graham number
3.09
-
0.90
71.00%
87.71
9,677.75%
35.29
59.77%
18.25
48.27%
15.05
17.54%
30.57
103.12%
25.42
16.87%
7.99
68.57%
6.42
19.65%
17.95
179.72%
income quality
-0.68
-
2.97
537.00%
-0.06
102.08%
0.16
352.55%
0.40
155.92%
0.38
4.90%
0.14
63.38%
0.05
65.22%
-1.03
2,222.85%
0.60
158.50%
-1.26
309.23%
intangibles to total assets
0.02
-
0.02
9.51%
0.76
4,397.76%
0.74
2.93%
0.66
10.25%
0.64
3.29%
0.59
8.23%
0.45
22.67%
0.50
9.44%
0.64
28.94%
0.72
12.82%
interest coverage
-146.66
-
-328.38
123.90%
-20.03
93.90%
-8.66
56.78%
-8.28
4.31%
-1.34
83.86%
1.19
188.99%
-3.84
422.98%
-649.97
16,815.37%
interest debt per share
0.27
-
0.01
-
2.69
22,946.39%
1.94
27.70%
1.34
30.84%
4.65
246.33%
4.57
1.81%
3.55
22.23%
5.25
47.65%
4.97
5.35%
inventory turnover
-2.82
-
-3.82
35.60%
-82.57
2,062.27%
4.18
105.06%
-3.42
181.87%
-1.58
53.90%
-2.13
35.39%
-2.49
16.69%
1.50B
60,391,776,115.16%
invested capital
0.33
-
0.17
-
0.12
29.86%
0.09
28.33%
0.40
364.57%
0.58
45.23%
0.40
30.37%
0.55
37.01%
0.49
12.11%
market cap
720.96M
-
720.96M
0%
304.31M
57.79%
666.46M
119.00%
791.52M
18.76%
1.54B
94.93%
745.39M
51.69%
1.36B
82.64%
2.38B
74.93%
2.63B
10.48%
3.67B
39.66%
net current asset value
9.36M
-
-39.27M
519.54%
103.53M
363.61%
-22.76M
121.98%
111.79M
591.19%
-44.96M
140.22%
-340.17M
656.62%
-204.45M
39.90%
-201.87M
1.26%
-479.82M
137.69%
-750.51M
56.41%
net debt to ebitda
1.03
-
0.32
-
-0.15
145.53%
2.93
2,084.11%
0.88
69.87%
-4.09
563.95%
0.82
119.99%
0.16
80.78%
39.12
24,795.22%
0.01
99.97%
net income per share
0.52
-
-0.66
226.09%
13.23
2,103.47%
-3.55
126.81%
-0.94
73.42%
-0.68
27.77%
-3.71
444.90%
-3.94
6.08%
-0.35
91.06%
-0.20
43.28%
-1.28
540.69%
operating cash flow per share
-0.36
-
-1.96
450.99%
-0.79
59.83%
-0.79
0.07%
-0.43
44.91%
-0.27
38.54%
-0.52
93.90%
-0.19
63.10%
0.45
335.65%
-0.12
127.39%
1.28
1,139.44%
payables turnover
15.19
-
3.44
-
3.54
2.86%
6.27
77.47%
2.23
64.40%
13.69
512.69%
21.87
59.81%
6.84
68.71%
18.11
164.63%
31.16
72.07%
receivables turnover
2.44
-
4.75
-
6.26
31.60%
6.31
0.85%
7.62
20.76%
10.93
43.50%
8.09
25.96%
6.95
14.11%
5.31
23.64%
4.40
17.19%
research and ddevelopement to revenue
0.01
-
return on tangible assets
0.20
-
-0.67
436.41%
1.37
303.56%
-0.51
137.21%
-0.14
73.07%
-0.09
37.86%
-0.49
481.84%
-0.45
9.63%
-0.04
90.51%
-0.03
32.41%
-0.19
569.20%
revenue per share
0.67
-
3.86
-
5.64
46.42%
6.76
19.74%
8.11
19.96%
10.28
26.74%
12.04
17.15%
10.55
12.37%
14.43
36.78%
17.65
22.34%
roe
0.64
-
12.20
1,790.91%
0.51
95.80%
-0.23
144.41%
-0.06
73.61%
-0.05
23.29%
-0.33
619.65%
-0.54
62.83%
-0.04
91.91%
-0.02
50.16%
-0.11
424.64%
roic
-0.51
-
12.20
2,483.80%
-0.06
100.51%
-0.28
346.83%
-0.06
78.68%
-0.04
34.89%
-0.08
115.24%
-0.04
56.61%
0.03
182.82%
-0.01
143.56%
26.72
207,434.28%
sales general and administrative to revenue
0.61
-
0.78
-
0.63
18.65%
0.47
25.20%
0.49
3.30%
0.46
4.99%
0.30
34.56%
0.24
20.41%
shareholders equity per share
0.81
-
-0.05
106.67%
25.84
47,819.36%
15.60
39.63%
15.71
0.69%
14.79
5.85%
11.20
24.28%
7.30
34.85%
8.06
10.47%
9.17
13.81%
11.20
22.12%
stock based compensation to revenue
0.00
-
0.15
-
0.09
41.78%
0.05
46.92%
0.03
40.24%
0.02
34.29%
0.01
22.58%
0.02
28.84%
0.03
36.56%
0.02
17.95%
tangible asset value
29.47M
-
-2.72M
109.22%
162.52M
6,081.74%
26.62M
83.62%
176.86M
564.33%
86.20M
51.26%
48.52M
43.71%
-3.21M
106.61%
-12.45M
288.27%
-306.14M
2,359.36%
-693.32M
126.47%
tangible book value per share
0.77
-
-0.07
109.22%
6.47
9,199.55%
0.59
90.86%
2.75
364.88%
1.11
59.45%
0.59
47.14%
-0.04
106.41%
-0.14
283.13%
-3.27
2,159.04%
-6.23
90.74%
working capital
50.97M
-
173K
99.66%
124.96M
72,129.48%
133.03M
6.46%
245.48M
84.54%
341.21M
38.99%
36.03M
89.44%
144.35M
300.63%
78.47M
45.64%
44.61M
43.15%
9.43M
78.86%

All numbers in USD (except ratios and percentages)